MARKET INTRODUCTION
Insulin API are generally biosimilars, which include regular human insulin, insulin analogues. These are used to formulate different dosages that are delivered through different delivery devices.
MARKET DYNAMICS
The insulin API market growth is estimated to grow due to increasing production of insulin to meet the rising demand from the diabetic people, Growing product development and biological based insulin production are expected to influence the growth of market. The developing regions such as Asia Pacific and Middle East and Africa are expected to serve vital growth opportunities due to growing API manufacturing.
MARKET SCOPE
The "Insulin API Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of insulin API market with detailed market segmentation by type, and application. The insulin API market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in insulin API market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The insulin API market is segmented on the basis of, type and application. Based on type, the market is classified as communication and regular human insulin, and insulin analogue. Based on application, the market is classified as fast-acting, long-acting, and premix.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the insulin API market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The insulin API market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting insulin API market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the insulin API market in these regions.
MARKET PLAYERS
The report covers key developments in the insulin API market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from insulin API market are anticipated to have lucrative growth opportunities in the future with the rising demand for insulin API in the global market. Below mentioned is the list of few companies engaged in the insulin API market.
The report also includes the profiles of key players in insulin API market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Eli Lilly and Company
Biocon
Novo Nordisk A/S
Amphastar Pharmaceuticals
Julphar
LGM Pharma
Torrent Pharmaceuticals Ltd.
Bachem AG
MannKind Corporation.
Sanofi
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Insulin API Market - By Type
1.3.2 Insulin API Market - By Application
1.3.3 Insulin API Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INSULIN API MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INSULIN API MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INSULIN API MARKET - GLOBAL MARKET ANALYSIS
6.1. INSULIN API - GLOBAL MARKET OVERVIEW
6.2. INSULIN API - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INSULIN API MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. REGULAR HUMAN INSULIN
7.3.1. Overview
7.3.2. Regular Human Insulin Market Forecast and Analysis
7.4. INSULIN ANALOGUE
7.4.1. Overview
7.4.2. Insulin Analogue Market Forecast and Analysis
8. INSULIN API MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. FAST-ACTING
8.3.1. Overview
8.3.2. Fast-acting Market Forecast and Analysis
8.4. LONG-ACTING
8.4.1. Overview
8.4.2. Long-acting Market Forecast and Analysis
8.5. PREMIX
8.5.1. Overview
8.5.2. Premix Market Forecast and Analysis
9. INSULIN API MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Insulin API Market Overview
9.1.2 North America Insulin API Market Forecasts and Analysis
9.1.3 North America Insulin API Market Forecasts and Analysis - By Type
9.1.4 North America Insulin API Market Forecasts and Analysis - By Application
9.1.5 North America Insulin API Market Forecasts and Analysis - By Countries
9.1.5.1 United States Insulin API Market
9.1.5.1.1 United States Insulin API Market by Type
9.1.5.1.2 United States Insulin API Market by Application
9.1.5.2 Canada Insulin API Market
9.1.5.2.1 Canada Insulin API Market by Type
9.1.5.2.2 Canada Insulin API Market by Application
9.1.5.3 Mexico Insulin API Market
9.1.5.3.1 Mexico Insulin API Market by Type
9.1.5.3.2 Mexico Insulin API Market by Application
9.2. EUROPE
9.2.1 Europe Insulin API Market Overview
9.2.2 Europe Insulin API Market Forecasts and Analysis
9.2.3 Europe Insulin API Market Forecasts and Analysis - By Type
9.2.4 Europe Insulin API Market Forecasts and Analysis - By Application
9.2.5 Europe Insulin API Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Insulin API Market
9.2.5.1.1 Germany Insulin API Market by Type
9.2.5.1.2 Germany Insulin API Market by Application
9.2.5.2 France Insulin API Market
9.2.5.2.1 France Insulin API Market by Type
9.2.5.2.2 France Insulin API Market by Application
9.2.5.3 Italy Insulin API Market
9.2.5.3.1 Italy Insulin API Market by Type
9.2.5.3.2 Italy Insulin API Market by Application
9.2.5.4 Spain Insulin API Market
9.2.5.4.1 Spain Insulin API Market by Type
9.2.5.4.2 Spain Insulin API Market by Application
9.2.5.5 United Kingdom Insulin API Market
9.2.5.5.1 United Kingdom Insulin API Market by Type
9.2.5.5.2 United Kingdom Insulin API Market by Application
9.2.5.6 Rest of Europe Insulin API Market
9.2.5.6.1 Rest of Europe Insulin API Market by Type
9.2.5.6.2 Rest of Europe Insulin API Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Insulin API Market Overview
9.3.2 Asia-Pacific Insulin API Market Forecasts and Analysis
9.3.3 Asia-Pacific Insulin API Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Insulin API Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Insulin API Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Insulin API Market
9.3.5.1.1 Australia Insulin API Market by Type
9.3.5.1.2 Australia Insulin API Market by Application
9.3.5.2 China Insulin API Market
9.3.5.2.1 China Insulin API Market by Type
9.3.5.2.2 China Insulin API Market by Application
9.3.5.3 India Insulin API Market
9.3.5.3.1 India Insulin API Market by Type
9.3.5.3.2 India Insulin API Market by Application
9.3.5.4 Japan Insulin API Market
9.3.5.4.1 Japan Insulin API Market by Type
9.3.5.4.2 Japan Insulin API Market by Application
9.3.5.5 South Korea Insulin API Market
9.3.5.5.1 South Korea Insulin API Market by Type
9.3.5.5.2 South Korea Insulin API Market by Application
9.3.5.6 Rest of Asia-Pacific Insulin API Market
9.3.5.6.1 Rest of Asia-Pacific Insulin API Market by Type
9.3.5.6.2 Rest of Asia-Pacific Insulin API Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Insulin API Market Overview
9.4.2 Middle East and Africa Insulin API Market Forecasts and Analysis
9.4.3 Middle East and Africa Insulin API Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Insulin API Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Insulin API Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Insulin API Market
9.4.5.1.1 South Africa Insulin API Market by Type
9.4.5.1.2 South Africa Insulin API Market by Application
9.4.5.2 Saudi Arabia Insulin API Market
9.4.5.2.1 Saudi Arabia Insulin API Market by Type
9.4.5.2.2 Saudi Arabia Insulin API Market by Application
9.4.5.3 U.A.E Insulin API Market
9.4.5.3.1 U.A.E Insulin API Market by Type
9.4.5.3.2 U.A.E Insulin API Market by Application
9.4.5.4 Rest of Middle East and Africa Insulin API Market
9.4.5.4.1 Rest of Middle East and Africa Insulin API Market by Type
9.4.5.4.2 Rest of Middle East and Africa Insulin API Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Insulin API Market Overview
9.5.2 South and Central America Insulin API Market Forecasts and Analysis
9.5.3 South and Central America Insulin API Market Forecasts and Analysis - By Type
9.5.4 South and Central America Insulin API Market Forecasts and Analysis - By Application
9.5.5 South and Central America Insulin API Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Insulin API Market
9.5.5.1.1 Brazil Insulin API Market by Type
9.5.5.1.2 Brazil Insulin API Market by Application
9.5.5.2 Argentina Insulin API Market
9.5.5.2.1 Argentina Insulin API Market by Type
9.5.5.2.2 Argentina Insulin API Market by Application
9.5.5.3 Rest of South and Central America Insulin API Market
9.5.5.3.1 Rest of South and Central America Insulin API Market by Type
9.5.5.3.2 Rest of South and Central America Insulin API Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INSULIN API MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INSULIN API MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOCON
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVO NORDISK A/S
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMPHASTAR PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JULPHAR
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LGM PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TORRENT PHARMACEUTICALS LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BACHEM AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MANNKIND CORPORATION.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Eli Lilly and Company
2. Biocon
3. Novo Nordisk A/S
4. Amphastar Pharmaceuticals
5. Julphar
6. LGM Pharma
7. Torrent Pharmaceuticals Ltd.
8. Bachem AG
9. MannKind Corporation.
10. Sanofi